- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Radiopharmaceuticals market size is estimated to be worth US$ 6956.7 million in 2021 and is forecast to a readjusted size of USD 11660 million by 2028 with a CAGR of 7.7% during review period. Oncology accounting for % of the Radiopharmaceuticals global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Diagnostic Radioisotopes segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Radiopharmaceuticals include Bracco Imaging, Bayer, Mallinckrodt, Nordion, and Triad Isotopes, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Radiopharmaceuticals market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Market segment by Application can be divided into
Oncology
Cardiology
Other
The key market players for global Radiopharmaceuticals market are listed below:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceuticals, with price, sales, revenue and global market share of Radiopharmaceuticals from 2019 to 2022.
Chapter 3, the Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radiopharmaceuticals.
Chapter 13, 14, and 15, to describe Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceuticals Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceuticals Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceuticals Market Size & Forecast
1.4.1 Global Radiopharmaceuticals Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Radiopharmaceuticals Sales in Volume (2017-2028)
1.4.3 Global Radiopharmaceuticals Price (2017-2028)
1.5 Global Radiopharmaceuticals Production Capacity Analysis
1.5.1 Global Radiopharmaceuticals Total Production Capacity (2017-2028)
1.5.2 Global Radiopharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Radiopharmaceuticals Market Drivers
1.6.2 Radiopharmaceuticals Market Restraints
1.6.3 Radiopharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Radiopharmaceuticals Product and Services
2.1.4 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Radiopharmaceuticals Product and Services
2.2.4 Bayer Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Radiopharmaceuticals Product and Services
2.3.4 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Radiopharmaceuticals Product and Services
2.4.4 Nordion Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Radiopharmaceuticals Product and Services
2.5.4 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Radiopharmaceuticals Product and Services
2.6.4 Lantheus Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 IBA Group
2.7.1 IBA Group Details
2.7.2 IBA Group Major Business
2.7.3 IBA Group Radiopharmaceuticals Product and Services
2.7.4 IBA Group Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Radiopharmaceuticals Product and Services
2.8.4 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 China Isotope & Radiation
2.9.1 China Isotope & Radiation Details
2.9.2 China Isotope & Radiation Major Business
2.9.3 China Isotope & Radiation Radiopharmaceuticals Product and Services
2.9.4 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Radiopharmaceuticals Product and Services
2.10.4 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Radiopharmaceuticals Product and Services
2.11.4 Eli Lilly Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Advanced Accelerator Applications
2.12.1 Advanced Accelerator Applications Details
2.12.2 Advanced Accelerator Applications Major Business
2.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product and Services
2.12.4 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business
2.13.3 SIEMENS Radiopharmaceuticals Product and Services
2.13.4 SIEMENS Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Radiopharmaceuticals Product and Services
2.14.4 Dongcheng Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Navidea
2.15.1 Navidea Details
2.15.2 Navidea Major Business
2.15.3 Navidea Radiopharmaceuticals Product and Services
2.15.4 Navidea Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Radiopharmaceuticals Breakdown Data by Manufacturer
3.1 Global Radiopharmaceuticals Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Radiopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Radiopharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceuticals Manufacturer Market Share in 2021
3.4.2 Top 6 Radiopharmaceuticals Manufacturer Market Share in 2021
3.5 Global Radiopharmaceuticals Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Radiopharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Radiopharmaceuticals Market Size by Region
4.1.1 Global Radiopharmaceuticals Sales in Volume by Region (2017-2028)
4.1.2 Global Radiopharmaceuticals Revenue by Region (2017-2028)
4.2 North America Radiopharmaceuticals Revenue (2017-2028)
4.3 Europe Radiopharmaceuticals Revenue (2017-2028)
4.4 Asia-Pacific Radiopharmaceuticals Revenue (2017-2028)
4.5 South America Radiopharmaceuticals Revenue (2017-2028)
4.6 Middle East and Africa Radiopharmaceuticals Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Radiopharmaceuticals Sales in Volume by Type (2017-2028)
5.2 Global Radiopharmaceuticals Revenue by Type (2017-2028)
5.3 Global Radiopharmaceuticals Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Radiopharmaceuticals Sales in Volume by Application (2017-2028)
6.2 Global Radiopharmaceuticals Revenue by Application (2017-2028)
6.3 Global Radiopharmaceuticals Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Radiopharmaceuticals Sales by Type (2017-2028)
7.2 North America Radiopharmaceuticals Sales by Application (2017-2028)
7.3 North America Radiopharmaceuticals Market Size by Country
7.3.1 North America Radiopharmaceuticals Sales in Volume by Country (2017-2028)
7.3.2 North America Radiopharmaceuticals Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Radiopharmaceuticals Sales by Type (2017-2028)
8.2 Europe Radiopharmaceuticals Sales by Application (2017-2028)
8.3 Europe Radiopharmaceuticals Market Size by Country
8.3.1 Europe Radiopharmaceuticals Sales in Volume by Country (2017-2028)
8.3.2 Europe Radiopharmaceuticals Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Radiopharmaceuticals Sales by Type (2017-2028)
9.2 Asia-Pacific Radiopharmaceuticals Sales by Application (2017-2028)
9.3 Asia-Pacific Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Radiopharmaceuticals Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Radiopharmaceuticals Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Radiopharmaceuticals Sales by Type (2017-2028)
10.2 South America Radiopharmaceuticals Sales by Application (2017-2028)
10.3 South America Radiopharmaceuticals Market Size by Country
10.3.1 South America Radiopharmaceuticals Sales in Volume by Country (2017-2028)
10.3.2 South America Radiopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Radiopharmaceuticals Sales by Type (2017-2028)
11.2 Middle East & Africa Radiopharmaceuticals Sales by Application (2017-2028)
11.3 Middle East & Africa Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Radiopharmaceuticals Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Radiopharmaceuticals Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Radiopharmaceuticals and Key Manufacturers
12.2 Manufacturing Costs Percentage of Radiopharmaceuticals
12.3 Radiopharmaceuticals Production Process
12.4 Radiopharmaceuticals Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Radiopharmaceuticals Typical Distributors
13.3 Radiopharmaceuticals Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceuticals Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Radiopharmaceuticals Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Radiopharmaceuticals Product and Services
Table 6. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Radiopharmaceuticals Product and Services
Table 10. Bayer Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Radiopharmaceuticals Product and Services
Table 14. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Nordion Basic Information, Manufacturing Base and Competitors
Table 16. Nordion Major Business
Table 17. Nordion Radiopharmaceuticals Product and Services
Table 18. Nordion Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 20. Triad Isotopes Major Business
Table 21. Triad Isotopes Radiopharmaceuticals Product and Services
Table 22. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Lantheus Basic Information, Manufacturing Base and Competitors
Table 24. Lantheus Major Business
Table 25. Lantheus Radiopharmaceuticals Product and Services
Table 26. Lantheus Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. IBA Group Basic Information, Manufacturing Base and Competitors
Table 28. IBA Group Major Business
Table 29. IBA Group Radiopharmaceuticals Product and Services
Table 30. IBA Group Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. GE Healthcare Major Business
Table 33. GE Healthcare Radiopharmaceuticals Product and Services
Table 34. GE Healthcare Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 36. China Isotope & Radiation Major Business
Table 37. China Isotope & Radiation Radiopharmaceuticals Product and Services
Table 38. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Jubilant Pharma Major Business
Table 41. Jubilant Pharma Radiopharmaceuticals Product and Services
Table 42. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Radiopharmaceuticals Product and Services
Table 46. Eli Lilly Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 48. Advanced Accelerator Applications Major Business
Table 49. Advanced Accelerator Applications Radiopharmaceuticals Product and Services
Table 50. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 52. SIEMENS Major Business
Table 53. SIEMENS Radiopharmaceuticals Product and Services
Table 54. SIEMENS Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 56. Dongcheng Major Business
Table 57. Dongcheng Radiopharmaceuticals Product and Services
Table 58. Dongcheng Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Navidea Basic Information, Manufacturing Base and Competitors
Table 60. Navidea Major Business
Table 61. Navidea Radiopharmaceuticals Product and Services
Table 62. Navidea Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Global Radiopharmaceuticals Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Dose)
Table 64. Global Radiopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 65. Market Position of Manufacturers in Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 66. Global Radiopharmaceuticals Production Capacity by Company, (K Dose): 2020 VS 2021
Table 67. Head Office and Radiopharmaceuticals Production Site of Key Manufacturer
Table 68. Radiopharmaceuticals New Entrant and Capacity Expansion Plans
Table 69. Radiopharmaceuticals Mergers & Acquisitions in the Past Five Years
Table 70. Global Radiopharmaceuticals Sales by Region (2017-2022) & (K Dose)
Table 71. Global Radiopharmaceuticals Sales by Region (2023-2028) & (K Dose)
Table 72. Global Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 73. Global Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 74. Global Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 75. Global Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
Table 76. Global Radiopharmaceuticals Revenue by Type (2017-2022) & (USD Million)
Table 77. Global Radiopharmaceuticals Revenue by Type (2023-2028) & (USD Million)
Table 78. Global Radiopharmaceuticals Price by Type (2017-2022) & (US$/Dose)
Table 79. Global Radiopharmaceuticals Price by Type (2023-2028) & (US$/Dose)
Table 80. Global Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 81. Global Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
Table 82. Global Radiopharmaceuticals Revenue by Application (2017-2022) & (USD Million)
Table 83. Global Radiopharmaceuticals Revenue by Application (2023-2028) & (USD Million)
Table 84. Global Radiopharmaceuticals Price by Application (2017-2022) & (US$/Dose)
Table 85. Global Radiopharmaceuticals Price by Application (2023-2028) & (US$/Dose)
Table 86. North America Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
Table 87. North America Radiopharmaceuticals Sales by Country (2023-2028) & (K Dose)
Table 88. North America Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 89. North America Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 90. North America Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 91. North America Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
Table 92. North America Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 93. North America Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
Table 94. Europe Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
Table 95. Europe Radiopharmaceuticals Sales by Country (2023-2028) & (K Dose)
Table 96. Europe Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 97. Europe Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 98. Europe Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 99. Europe Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
Table 100. Europe Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 101. Europe Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
Table 102. Asia-Pacific Radiopharmaceuticals Sales by Region (2017-2022) & (K Dose)
Table 103. Asia-Pacific Radiopharmaceuticals Sales by Region (2023-2028) & (K Dose)
Table 104. Asia-Pacific Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 105. Asia-Pacific Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 106. Asia-Pacific Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 107. Asia-Pacific Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
Table 108. Asia-Pacific Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 109. Asia-Pacific Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
Table 110. South America Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
Table 111. South America Radiopharmaceuticals Sales by Country (2023-2028) & (K Dose)
Table 112. South America Radiopharmaceuticals Revenue by Country (2017-2022) & (USD Million)
Table 113. South America Radiopharmaceuticals Revenue by Country (2023-2028) & (USD Million)
Table 114. South America Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 115. South America Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
Table 116. South America Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 117. South America Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
Table 118. Middle East & Africa Radiopharmaceuticals Sales by Region (2017-2022) & (K Dose)
Table 119. Middle East & Africa Radiopharmaceuticals Sales by Region (2023-2028) & (K Dose)
Table 120. Middle East & Africa Radiopharmaceuticals Revenue by Region (2017-2022) & (USD Million)
Table 121. Middle East & Africa Radiopharmaceuticals Revenue by Region (2023-2028) & (USD Million)
Table 122. Middle East & Africa Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
Table 123. Middle East & Africa Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
Table 124. Middle East & Africa Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
Table 125. Middle East & Africa Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
Table 126. Radiopharmaceuticals Raw Material
Table 127. Key Manufacturers of Radiopharmaceuticals Raw Materials
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Radiopharmaceuticals Typical Distributors
Table 131. Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. Radiopharmaceuticals Picture
Figure 2. Global Radiopharmaceuticals Revenue Market Share by Type in 2021
Figure 3. Diagnostic Radioisotopes
Figure 4. Therapeutic Radioisotopes
Figure 5. Global Radiopharmaceuticals Revenue Market Share by Application in 2021
Figure 6. Oncology
Figure 7. Cardiology
Figure 8. Other
Figure 9. Global Radiopharmaceuticals Revenue, (USD Million) & (K Dose): 2017 & 2021 & 2028
Figure 10. Global Radiopharmaceuticals Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Radiopharmaceuticals Sales (2017-2028) & (K Dose)
Figure 12. Global Radiopharmaceuticals Price (2017-2028) & (US$/Dose)
Figure 13. Global Radiopharmaceuticals Production Capacity (2017-2028) & (K Dose)
Figure 14. Global Radiopharmaceuticals Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Radiopharmaceuticals Market Drivers
Figure 16. Radiopharmaceuticals Market Restraints
Figure 17. Radiopharmaceuticals Market Trends
Figure 18. Global Radiopharmaceuticals Sales Market Share by Manufacturer in 2021
Figure 19. Global Radiopharmaceuticals Revenue Market Share by Manufacturer in 2021
Figure 20. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 24. Global Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 25. North America Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 26. Europe Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 28. South America Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Radiopharmaceuticals Revenue (2017-2028) & (USD Million)
Figure 30. Global Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 31. Global Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
Figure 32. Global Radiopharmaceuticals Price by Type (2017-2028) & (US$/Dose)
Figure 33. Global Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 34. Global Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
Figure 35. Global Radiopharmaceuticals Price by Application (2017-2028) & (US$/Dose)
Figure 36. North America Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 37. North America Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 38. North America Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 39. North America Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 40. United States Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 44. Europe Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 45. Europe Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 46. Europe Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 47. Germany Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 56. China Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 63. South America Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 64. South America Radiopharmaceuticals Sales Market Share by Country (2017-2028)
Figure 65. South America Radiopharmaceuticals Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Radiopharmaceuticals Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Radiopharmaceuticals Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Radiopharmaceuticals Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Radiopharmaceuticals Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2021
Figure 77. Manufacturing Process Analysis of Radiopharmaceuticals
Figure 78. Radiopharmaceuticals Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
